Literature DB >> 22907428

A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.

Y Yang1, L Zhou, L Lu, L Wang, X Li, P Jiang, L K Y Chan, T Zhang, J Yu, J Kwong, T H Cheung, T Chung, K Mak, H Sun, H Wang.   

Abstract

Aberrant expression and altered function of transcription factors (TFs) have vital roles in many aspects of tumor development and progression. In this study, we investigated the functional significance of a TF, Yin Yang1 (YY1) in tumorigenesis of endometrioid endometrial carcinoma (EEC). We demonstrated that YY1 is upregulated in EEC cell lines and primary tumors; and its expression is associated with tumor stages. Depletion of YY1 inhibits EEC cell proliferation and migration both in vitro and in vivo, whereas overexpression of YY1 promotes EEC cell growth. These results suggest that YY1 functions as an oncogenic factor in EEC. Transcriptome analysis revealed a significant effect of YY1 on critical aspects of EEC tumorigenesis through inhibition of APC expression. Further mechanistic investigation uncovered a new epigenetic silencing mode of APC by YY1 through recruitment of EZH2 and trimethylation of histone 3 lysine 27 on its promoter region. Moreover, YY1 overexpression was found to be a consequence of miR-193a-5p downregulation through direct miR-193a-5p-YY1 interplay. Our results therefore establish a novel miR-193a-5p-YY1-APC axis, which contributes to EEC development, and may serve as future intervention target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907428     DOI: 10.1038/onc.2012.360

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Linc-YY1 promotes myogenic differentiation and muscle regeneration through an interaction with the transcription factor YY1.

Authors:  Liang Zhou; Kun Sun; Yu Zhao; Suyang Zhang; Xuecong Wang; Yuying Li; Leina Lu; Xiaona Chen; Fengyuan Chen; Xichen Bao; Xihua Zhu; Lijun Wang; Ling-Yin Tang; Miguel A Esteban; Chi-Chiu Wang; Ralf Jauch; Hao Sun; Huating Wang
Journal:  Nat Commun       Date:  2015-12-11       Impact factor: 14.919

2.  LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration.

Authors:  Lijun Wang; Yu Zhao; Xichen Bao; Xihua Zhu; Yvonne Ka-Yin Kwok; Kun Sun; Xiaona Chen; Yongheng Huang; Ralf Jauch; Miguel A Esteban; Hao Sun; Huating Wang
Journal:  Cell Res       Date:  2015-02-17       Impact factor: 25.617

3.  Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Authors:  Peng Zhang; Deng-Bo Ji; Hai-Bo Han; Yun-Fei Shi; Chang-Zheng Du; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 4.  Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.

Authors:  Anne Arah Cho; Benjamin Bonavida
Journal:  Crit Rev Oncog       Date:  2017

5.  A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding.

Authors:  Jodie N Painter; Susanne Kaufmann; Tracy A O'Mara; Kristine M Hillman; Haran Sivakumaran; Hatef Darabi; Timothy H T Cheng; John Pearson; Stephen Kazakoff; Nicola Waddell; Erling A Hoivik; Ellen L Goode; Rodney J Scott; Ian Tomlinson; Alison M Dunning; Douglas F Easton; Juliet D French; Helga B Salvesen; Pamela M Pollock; Deborah J Thompson; Amanda B Spurdle; Stacey L Edwards
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

6.  Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis.

Authors:  Leina Lu; Kun Sun; Xiaona Chen; Yu Zhao; Lijun Wang; Liang Zhou; Hao Sun; Huating Wang
Journal:  EMBO J       Date:  2013-08-13       Impact factor: 11.598

7.  Zfx-induced upregulation of UBE2J1 facilitates endometrial cancer progression via PI3K/AKT pathway.

Authors:  Dexin Yang; Xin Ma; Jie Xu; Ke Jia; Xiaoli Liu; Ping Zhang
Journal:  Cancer Biol Ther       Date:  2021-02-26       Impact factor: 4.742

8.  Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer.

Authors:  Liyun Luo; Zhijie Zhang; Ni Qiu; Li Ling; Xiaoting Jia; Ying Song; Hongsheng Li; Jiansheng Li; Hui Lyu; Hao Liu; Zhimin He; Bolin Liu; Guopei Zheng
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 9.  APC Promoter Methylation in Gastrointestinal Cancer.

Authors:  Lila Zhu; Xinyu Li; Ying Yuan; Caixia Dong; Mengyuan Yang
Journal:  Front Oncol       Date:  2021-04-23       Impact factor: 6.244

Review 10.  The Role of Transcription Factor YY1 in the Biology of Cancer.

Authors:  Neeraj Agarwal; Dan Theodorescu
Journal:  Crit Rev Oncog       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.